CLE3AR Study

Abstract

Intraluminal thrombotic catheter occlusions are associated with a greater risk of delayed treatment, morbidity, and mortality and higher healthcare costs. Methods:The Vascular Access Specialist Team at Hartford Hospital used Lean Six Sigma methodology to identify and address waste, variability, and defects associated with occlusion management. Interventions:Beginning in 2015, all central venous catheter occlusions in acute inpatient care were assessed by a vascular access nurse specialist. First, the decisions to treat with tissue plasminogen activator were determined using a catheter patency algorithm. Second, negative displacement needleless connectors were replaced by antireflux needleless connectors to reduce unintentional blood reflux and other complications associated with intraluminal thrombotic catheter occlusion. Results:A total of 159 934 central line days were reported between 2014 and 2020. The hospital achieved a 71.3% reduction in annual tissue plasminogen activator used for occlusions over the study period. There was a sustained decrease in annual average needleless connector consumption of 41% after switching to antireflux needleless connectors in 2015. The 5-year cost savings for these 2 interventions were estimated to be $356 005. Conclusions:Lean occlusion management interventions were associated with reduced pharmacy use, medical supply waste, and spending, which have been sustained for over a 5-year period.

Totally Implantable Venous Access Device Care Practices and Experiences of Pediatric and Adult Oncology Nurses

“…27 To reduce complications related to central venous catheters, it is recommended that evidence-based practices and studies should be followed. 19,[28][29][30]…”

“…Following the guidelines and knowing the complication rates in clinics are imperative for improvements to be made in reducing complications and ensuring the continuity of TIVADs 27. To reduce complications related to central venous catheters, it is recommended that evidence-based practices and studies should be followed 19,28-30…”